Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Moderna Inc (MRNA)

Healthcare Biotechnology
54.80 $
-5.4% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Moderna Inc (MRNA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 93.3% of the shares are freely tradable; institutional investors hold 79.0%.

Ownership Structure

Institutional ownership
79.0%
Insiders
7.3%
Float
93.3%
Short % of float
18.1%
Shares Outstanding
397Mio.

Largest Shareholders

Institutions

Institutions MRNA
Name Stake (%) Shares Change (%) Date
FMR Inc 11.51 45,672,024 +62.9 03/31/2026
Vanguard Group Inc 10.48 41,584,782 +1.0 12/31/2025
BlackRock Inc 7.47 29,635,876 -8.8 03/31/2026
Vanguard Capital Management, LLC 5.76 22,872,458 +0.0 03/31/2026
Baillie Gifford & Co Limited. 5.04 19,985,876 -2.9 03/31/2026
Capital World Investors 4.71 18,697,694 +45.8 03/31/2026
Vanguard Portfolio Management, LLC 3.94 15,616,367 +0.0 03/31/2026
State Street Corp 3.75 14,861,409 -9.2 03/31/2026

Funds

Funds MRNA
Name Stake (%) Shares Change (%) Date
Capital Group Growth Fnd of Amer Comp 3.15 12,500,000 +31.3 03/31/2026
American Funds Growth Fund of Amer A 3.15 12,500,000 +31.3 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
15. Jul 2026 Hoge Stephen President Sell 53,336 67.60 3,605,514
15. Jul 2026 Hoge Stephen President Other 16,110 19.15 308,507
15. Jul 2026 Hoge Stephen President Other 37,226 19.15 712,878

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?